THIADIAZINE DERIVATIVES
To provide modulators of α7 nicotinic acetylcholine receptor activity.SOLUTION: The present invention provides a compound of formula (I) or its pharmaceutically acceptable salt thereof, biologically active metabolite, prodrug, racemate, enantiomer, diastereomer, solvate, or hydrate. Specifically, 5-...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PAL TAPOLCSANYI ESRTER GABOR ERSZEBET JABLONKAI ANDRAS VISEGRADI ZSOLT NEMETHY JANOS ELES ISTVAN LEDNECZKI GYORGY ISTVAN LEVAY JOZSEF LEVENTE PETRO GYORGY SELENYI |
| description | To provide modulators of α7 nicotinic acetylcholine receptor activity.SOLUTION: The present invention provides a compound of formula (I) or its pharmaceutically acceptable salt thereof, biologically active metabolite, prodrug, racemate, enantiomer, diastereomer, solvate, or hydrate. Specifically, 5-(3,4-dimethoxyphenyl)-2-methyl-N-(3-methylphenyl)-1,1-dioxo-2H-1λ6,2,6-thiadiazine-3-carboxamide is illustrated.SELECTED DRAWING: None
【課題】α７ニコチン性アセチルコリン受容体活性の調節薬を提供する。【解決手段】下記式（Ｉ）の化合物：TIFF2024056879000087.tif46170またはその薬学的に許容される塩、生物学的に活性な代謝産物、プロドラッグ、ラセミ体、エナチオマー、ジアステレオマー、溶媒和物、もしくは水和物を提供する。具体的には、例えば５－（３，４－ジメトキシフェニル）－２－メチル－Ｎ－（３－メチルフェニル）－１，１－ジオキソ－２Ｈ－１λ６，２，６－チアジアジン－３－カルボキサミドが示される。【選択図】なし |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2024056879A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2024056879A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2024056879A3</originalsourceid><addsrcrecordid>eNrjZBAP8fB0dPF0jPL0c1VwcQ3yDHMM8QxzDeZhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGRiYGpmYW5paOxkQpAgAhTyAY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THIADIAZINE DERIVATIVES</title><source>esp@cenet</source><creator>PAL TAPOLCSANYI ; ESRTER GABOR ; ERSZEBET JABLONKAI ; ANDRAS VISEGRADI ; ZSOLT NEMETHY ; JANOS ELES ; ISTVAN LEDNECZKI ; GYORGY ISTVAN LEVAY ; JOZSEF LEVENTE PETRO ; GYORGY SELENYI</creator><creatorcontrib>PAL TAPOLCSANYI ; ESRTER GABOR ; ERSZEBET JABLONKAI ; ANDRAS VISEGRADI ; ZSOLT NEMETHY ; JANOS ELES ; ISTVAN LEDNECZKI ; GYORGY ISTVAN LEVAY ; JOZSEF LEVENTE PETRO ; GYORGY SELENYI</creatorcontrib><description>To provide modulators of α7 nicotinic acetylcholine receptor activity.SOLUTION: The present invention provides a compound of formula (I) or its pharmaceutically acceptable salt thereof, biologically active metabolite, prodrug, racemate, enantiomer, diastereomer, solvate, or hydrate. Specifically, 5-(3,4-dimethoxyphenyl)-2-methyl-N-(3-methylphenyl)-1,1-dioxo-2H-1λ6,2,6-thiadiazine-3-carboxamide is illustrated.SELECTED DRAWING: None
【課題】α７ニコチン性アセチルコリン受容体活性の調節薬を提供する。【解決手段】下記式（Ｉ）の化合物：TIFF2024056879000087.tif46170またはその薬学的に許容される塩、生物学的に活性な代謝産物、プロドラッグ、ラセミ体、エナチオマー、ジアステレオマー、溶媒和物、もしくは水和物を提供する。具体的には、例えば５－（３，４－ジメトキシフェニル）－２－メチル－Ｎ－（３－メチルフェニル）－１，１－ジオキソ－２Ｈ－１λ６，２，６－チアジアジン－３－カルボキサミドが示される。【選択図】なし</description><language>eng ; jpn</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240423&DB=EPODOC&CC=JP&NR=2024056879A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240423&DB=EPODOC&CC=JP&NR=2024056879A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PAL TAPOLCSANYI</creatorcontrib><creatorcontrib>ESRTER GABOR</creatorcontrib><creatorcontrib>ERSZEBET JABLONKAI</creatorcontrib><creatorcontrib>ANDRAS VISEGRADI</creatorcontrib><creatorcontrib>ZSOLT NEMETHY</creatorcontrib><creatorcontrib>JANOS ELES</creatorcontrib><creatorcontrib>ISTVAN LEDNECZKI</creatorcontrib><creatorcontrib>GYORGY ISTVAN LEVAY</creatorcontrib><creatorcontrib>JOZSEF LEVENTE PETRO</creatorcontrib><creatorcontrib>GYORGY SELENYI</creatorcontrib><title>THIADIAZINE DERIVATIVES</title><description>To provide modulators of α7 nicotinic acetylcholine receptor activity.SOLUTION: The present invention provides a compound of formula (I) or its pharmaceutically acceptable salt thereof, biologically active metabolite, prodrug, racemate, enantiomer, diastereomer, solvate, or hydrate. Specifically, 5-(3,4-dimethoxyphenyl)-2-methyl-N-(3-methylphenyl)-1,1-dioxo-2H-1λ6,2,6-thiadiazine-3-carboxamide is illustrated.SELECTED DRAWING: None
【課題】α７ニコチン性アセチルコリン受容体活性の調節薬を提供する。【解決手段】下記式（Ｉ）の化合物：TIFF2024056879000087.tif46170またはその薬学的に許容される塩、生物学的に活性な代謝産物、プロドラッグ、ラセミ体、エナチオマー、ジアステレオマー、溶媒和物、もしくは水和物を提供する。具体的には、例えば５－（３，４－ジメトキシフェニル）－２－メチル－Ｎ－（３－メチルフェニル）－１，１－ジオキソ－２Ｈ－１λ６，２，６－チアジアジン－３－カルボキサミドが示される。【選択図】なし</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBAP8fB0dPF0jPL0c1VwcQ3yDHMM8QxzDeZhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGRiYGpmYW5paOxkQpAgAhTyAY</recordid><startdate>20240423</startdate><enddate>20240423</enddate><creator>PAL TAPOLCSANYI</creator><creator>ESRTER GABOR</creator><creator>ERSZEBET JABLONKAI</creator><creator>ANDRAS VISEGRADI</creator><creator>ZSOLT NEMETHY</creator><creator>JANOS ELES</creator><creator>ISTVAN LEDNECZKI</creator><creator>GYORGY ISTVAN LEVAY</creator><creator>JOZSEF LEVENTE PETRO</creator><creator>GYORGY SELENYI</creator><scope>EVB</scope></search><sort><creationdate>20240423</creationdate><title>THIADIAZINE DERIVATIVES</title><author>PAL TAPOLCSANYI ; ESRTER GABOR ; ERSZEBET JABLONKAI ; ANDRAS VISEGRADI ; ZSOLT NEMETHY ; JANOS ELES ; ISTVAN LEDNECZKI ; GYORGY ISTVAN LEVAY ; JOZSEF LEVENTE PETRO ; GYORGY SELENYI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2024056879A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PAL TAPOLCSANYI</creatorcontrib><creatorcontrib>ESRTER GABOR</creatorcontrib><creatorcontrib>ERSZEBET JABLONKAI</creatorcontrib><creatorcontrib>ANDRAS VISEGRADI</creatorcontrib><creatorcontrib>ZSOLT NEMETHY</creatorcontrib><creatorcontrib>JANOS ELES</creatorcontrib><creatorcontrib>ISTVAN LEDNECZKI</creatorcontrib><creatorcontrib>GYORGY ISTVAN LEVAY</creatorcontrib><creatorcontrib>JOZSEF LEVENTE PETRO</creatorcontrib><creatorcontrib>GYORGY SELENYI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PAL TAPOLCSANYI</au><au>ESRTER GABOR</au><au>ERSZEBET JABLONKAI</au><au>ANDRAS VISEGRADI</au><au>ZSOLT NEMETHY</au><au>JANOS ELES</au><au>ISTVAN LEDNECZKI</au><au>GYORGY ISTVAN LEVAY</au><au>JOZSEF LEVENTE PETRO</au><au>GYORGY SELENYI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THIADIAZINE DERIVATIVES</title><date>2024-04-23</date><risdate>2024</risdate><abstract>To provide modulators of α7 nicotinic acetylcholine receptor activity.SOLUTION: The present invention provides a compound of formula (I) or its pharmaceutically acceptable salt thereof, biologically active metabolite, prodrug, racemate, enantiomer, diastereomer, solvate, or hydrate. Specifically, 5-(3,4-dimethoxyphenyl)-2-methyl-N-(3-methylphenyl)-1,1-dioxo-2H-1λ6,2,6-thiadiazine-3-carboxamide is illustrated.SELECTED DRAWING: None
【課題】α７ニコチン性アセチルコリン受容体活性の調節薬を提供する。【解決手段】下記式（Ｉ）の化合物：TIFF2024056879000087.tif46170またはその薬学的に許容される塩、生物学的に活性な代謝産物、プロドラッグ、ラセミ体、エナチオマー、ジアステレオマー、溶媒和物、もしくは水和物を提供する。具体的には、例えば５－（３，４－ジメトキシフェニル）－２－メチル－Ｎ－（３－メチルフェニル）－１，１－ジオキソ－２Ｈ－１λ６，２，６－チアジアジン－３－カルボキサミドが示される。【選択図】なし</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; jpn |
| recordid | cdi_epo_espacenet_JP2024056879A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | THIADIAZINE DERIVATIVES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T18%3A03%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PAL%20TAPOLCSANYI&rft.date=2024-04-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2024056879A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |